Photo of Rolf Svedjeholm

Rolf Svedjeholm

Visiting Professor


The focus of my research is on cardiac metabolism and monitoring, assessing and treating heart failure in association with cardiac surgery in a way that optimizes cardiac recovery. This is important because heart failure is the leading cause of death following heart surgery.



Jonas Holm, Farkas Vanky, Rolf Svedjeholm (2024) Association of Glutamate Infusion With Risk of Acute Kidney Injury After Coronary Artery Bypass Surgery A Pooled Analysis of 2 Randomized Clinical Trials JAMA Network Open, Vol. 7, Article e2351743 Continue to DOI


Rolf Svedjeholm, Gabriele Ferrari, Farkas Vanky, Örjan Friberg, Jonas Holm (2023) Glutamate infusion associated with reduced rises of p-Copeptin after coronary surgery: Substudy of GLUTAMICS II Acta Anaesthesiologica Scandinavica, Vol. 67, p. 1373-1382 Continue to DOI
Jonas Holm, Farkas Vanky, Rolf Svedjeholm (2023) Glutamate Infusion Reduces Myocardial Dysfunction after Coronary Artery Bypass Grafting According to NT-proBNP: Summary of 2 Randomized Controlled Trials (GLUTAmate for Metabolic Intervention in Coronary Surgery [GLUTAMICS I-II]) American Journal of Clinical Nutrition, Vol. 118, p. 930-937 Continue to DOI


Jonas Holm, Gabriele Ferrari, Anders Holmgren, Farkas Vanky, Örjan Friberg, Mårten Vidlund, Rolf Svedjeholm (2022) Effect of glutamate infusion on NT-proBNP after coronary artery bypass grafting in high-risk patients (GLUTAMICS II): A randomized controlled trial PLoS Medicine, Vol. 19, Article e1003997 Continue to DOI
Henrik Hultkvist, Eva Nylander, Eva Tamas, Rolf Svedjeholm, Jan Engvall, Jonas Holm, Eva Maret, Farkas Vanky (2022) Evaluation of left ventricular diastolic function in patients operated for aortic stenosis PLOS ONE, Vol. 17, Article e0263824 Continue to DOI